Sleep Apnea Treatment Devices Market Analysis & Forecast 2025-2031

The global sleep apnea treatment devices market is valued at USD 4.8 billion in 2023 and is expected to reach USD 9.6 billion by the end of 2026, growing at a CAGR of 7.2 % between 2017 and 2025.
 

Sleep apnea is defined as a reduction or cessation of breathing during sleep. The three types of sleep apnea are central apnea, obstructive apnea, and a mixture of central and obstructive apnea. Central sleep apnea is a condition when brain does not send the signals needed to breathe while collapse of the airway during sleep is known as obstructive sleep apnea. Undiagnosed or untreated sleep apnea can lead to serious complications such as heart attack, glaucoma, diabetes, cancer, and cognitive and behavioral disorders.
 

On the basis of product, sleep apnea treatment devices market is segmented into positive airway pressure (pap) devices, oxygen devices, oral appliances and adaptive servo ventilation (asv) devices. The PAP devices segment is estimated to account for the largest share of the global sleep apnea therapeutic devices market in 2023 while the oral appliances segment is projected to register the highest CAGR during the forecast period. On the basis of end-user, sleep apnea treatment devices market is segmented into home, hospitals and laboratories. The home care settings segment is estimated to account for the largest share of the global market due to preference for home care in sleep apnea diagnosed patients.
 

Rising number of people having sleep apnea disorder with changing lifestyle habits such as unhealthy sleep patterns, smoking and excess alcohol consumption causes sleeps related disorder is increasing demand for early diagnosis and growing patient awareness levels and further drive industry growth. New advancements in technology, new specifications, innovative concepts, new applications and upgrading the design of sleep apnea treatment devices have made these devices compact, comfortable, and easy to use for better performance is also supporting the growth of this market. However, high cost of sleep apnea devices and lack of patient compliance are proving as barrier for industry growth.
 

North America is the largest sleep apnea treatment devices market followed by Europe and Asia pacific. North America and Europe together accounting for more than 50% of the global market share in the organic elemental analyzer market. This is due to well-established healthcare infrastructure, high level of awareness, higher healthcare spending, developed regulatory framework and easy availability of these devices. Asia Pacific will remain as the fastest growing market in forecast period due to a large pool of patients, improvement in healthcare facilities, supportive government initiatives, increasing disposable income, growth of medical tourism and increasing investments by manufacturers especially in China and India.
 

Sleep Apnea Treatment Devices Market : Product Type

• Positive Airway Pressure (PAP) Devices
• Oxygen Devices
• Oral Appliances
• Adaptive Servo Ventialtion (ASV) Devices

Sleep Apnea Treatment Devices Market: Application

• Hospital
• Home Use

Sleep Apnea Treatment Devices Market : Competitive Analysis

Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study consists of following key players in Global Sleep Apnea Treatment Devices Market:

• ResMed
• Phlips Respironics
• Fisher & Paykel Healthcare
• DeVilbiss Healthcare
• Breas
• Apex
• Weinmann
• Teijin Pharma
• Curative Medical
• Covidien (Medtronic)
• Koike Medical
• Somnetics International
• Nidek Medical India
• SLS Medical Technology
• BMC Medical
• Curative Medical (China)
• Bejing Kangdu Medical
• Shangcha Beyond Medical

Sleep Apnea Treatment Devices Market Report

Global Sleep Apnea Treatment Devices Market Report delivers a comprehensive analysis of the following parameters: